Seelos Therapeutics
Seelos Corporation, a wholly-owned subsidiary of Seelos Therapeutics, Inc.
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001136261-22-000174
- Document
- 8-K
- Exhibit 99.1
- Press release, dated April 11, 2022.
- Signs a material agreement (1.01)
- Sells unregistered shares (3.02)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
